Teriflunomide
Back to searchMolecule Structure
Scientific Name
Teriflunomide
Description of the Drug
Teriflunomide is a pyrimidine synthesis inhibitor with anti-inflammatory and immunomodulatory properties used to treat patients with the relapsing-remitting form of multiple sclerosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08880
http://www.drugbank.ca/drugs/DB08880
Brand Name(s)
Aubagio
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Glenmark Pharmaceuticals Inc, Msn Laboratories Private Ltd, Teva Pharmaceuticals Usa Inc, Alembic Pharmaceuticals Ltd, Apotex Inc, Sandoz Inc, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Sola Pharmaceuticals, Accord Healthcare Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dihydroorotate dehydrogenase | SINGLE PROTEIN | INHIBITOR | CHEMBL1966 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL22661 | |||
DrugBank | DB08880 | |||
PubChem: Thomson Pharma | 15221873 | |||
PubChem | 54684141 | |||
Nikkaji | J994.777I | J690.639G | ||
PDBe | A26 | |||
BindingDB | 50018011 | |||
EPA CompTox Dashboard | DTXSID80893457 | |||
DrugCentral | 4634 | |||
Metabolights | MTBLC68540 | |||
Brenda | 147806 | 6758 | 55910 | 163092 |
ChemicalBook | CB5648113 | CB6464433 | CB02486749 | |
Guide to Pharmacology | 6844 | |||
rxnorm | AUBAGIO | TERIFLUNOMIDE | ||
PubChem: Drugs of the Future | 12014666 | |||
ChEBI | 68540 | |||
ZINC | ZINC000013512456 |